awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q55026900-67FE6137-CB7E-4CFC-B0A4-D9935D7213F5
Q55026900-67FE6137-CB7E-4CFC-B0A4-D9935D7213F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55026900-67FE6137-CB7E-4CFC-B0A4-D9935D7213F5
The magnitude of best tumor shrinkage during second-line targeted therapy affects progression-free survival but not overall survival in patients with metastatic renal cell carcinoma.
P2860
Q55026900-67FE6137-CB7E-4CFC-B0A4-D9935D7213F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55026900-67FE6137-CB7E-4CFC-B0A4-D9935D7213F5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e790daaaf5374c92df108f2f6d595f8798621c81
P2860
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma.